The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: Comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model

Val M. Runge, Jonmenjoy Biswas, Bernd J. Wintersperger, Shannon S. Baumann, Carney B. Jackson, Christoph U. Herborn, Tushar C Patel

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

OBJECTIVES: The objectives of this study were to analyze the differences in contrast enhancement using gadobenate dimeglumine (Gd-BOPTA or MultiHance) at 3 T versus 1.5 T and to compare Gd-BOPTA with a standard gadolinium chelate, gadopentetate dimeglumine (Gd-DTPA or Magnevist), at 3 T in a rat glioma model. MATERIALS AND METHODS: Twelve rats with surgically implanted gliomas were randomized to either comparing Gd-BOPTA at 1.5 T versus 3 T (n = 7) or comparing Gd-BOPTA and Gd-DTPA at 3 T (n = 5). Matched T1-weighted spin-echo techniques were used for both comparisons and the order of examinations was randomized. Signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and lesion enhancement (LE) were evaluated using a region-of-interest analysis. A veterinary histopathologist evaluated all brain specimens. RESULTS: In the evaluation of Gd-BOPTA at 3 T and 1.5 T, there were significant increases in SNR, LE, and CNR at 3 T. Average increases in brain and tumor SNR were 93% (P < 0.0001) and 92% (P < 0.0001), respectively. CNR increased by 121% (P < 0.0001). Comparison of Gd-BOPTA and Gd-DTPA at 3 T demonstrated significantly higher CNR and LE with Gd-BOPTA. CNR increased by 35% (P = 0.002). LE increased by 44% (P = 0.03). CONCLUSIONS: Gd-BOPTA provides significantly higher CNR at 3 T compared with 1.5 T and also demonstrates significantly higher CNR when compared with a standard Gd-chelate at 3 T. As a result of transient protein binding, Gd-BOPTA may be superior to standard gadolinium chelates in neurologic imaging at 3 T.

Original languageEnglish (US)
Pages (from-to)244-248
Number of pages5
JournalInvestigative Radiology
Volume41
Issue number3
DOIs
StatePublished - Mar 2006
Externally publishedYes

Fingerprint

Gadolinium
Brain Neoplasms
Magnetic Resonance Imaging
Gadolinium DTPA
Noise
Brain
Signal-To-Noise Ratio
Glioma
gadobenic acid
Protein Binding
Nervous System

Keywords

  • Brain neoplasms
  • Contrast enhancement
  • Gadobenate dimeglumine
  • Gadolinium chelates
  • Magnetic resonance

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging : Comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model. / Runge, Val M.; Biswas, Jonmenjoy; Wintersperger, Bernd J.; Baumann, Shannon S.; Jackson, Carney B.; Herborn, Christoph U.; Patel, Tushar C.

In: Investigative Radiology, Vol. 41, No. 3, 03.2006, p. 244-248.

Research output: Contribution to journalArticle

Runge, Val M. ; Biswas, Jonmenjoy ; Wintersperger, Bernd J. ; Baumann, Shannon S. ; Jackson, Carney B. ; Herborn, Christoph U. ; Patel, Tushar C. / The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging : Comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model. In: Investigative Radiology. 2006 ; Vol. 41, No. 3. pp. 244-248.
@article{7221d65d1d274f098c6a7f95f48c5c03,
title = "The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: Comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model",
abstract = "OBJECTIVES: The objectives of this study were to analyze the differences in contrast enhancement using gadobenate dimeglumine (Gd-BOPTA or MultiHance) at 3 T versus 1.5 T and to compare Gd-BOPTA with a standard gadolinium chelate, gadopentetate dimeglumine (Gd-DTPA or Magnevist), at 3 T in a rat glioma model. MATERIALS AND METHODS: Twelve rats with surgically implanted gliomas were randomized to either comparing Gd-BOPTA at 1.5 T versus 3 T (n = 7) or comparing Gd-BOPTA and Gd-DTPA at 3 T (n = 5). Matched T1-weighted spin-echo techniques were used for both comparisons and the order of examinations was randomized. Signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and lesion enhancement (LE) were evaluated using a region-of-interest analysis. A veterinary histopathologist evaluated all brain specimens. RESULTS: In the evaluation of Gd-BOPTA at 3 T and 1.5 T, there were significant increases in SNR, LE, and CNR at 3 T. Average increases in brain and tumor SNR were 93{\%} (P < 0.0001) and 92{\%} (P < 0.0001), respectively. CNR increased by 121{\%} (P < 0.0001). Comparison of Gd-BOPTA and Gd-DTPA at 3 T demonstrated significantly higher CNR and LE with Gd-BOPTA. CNR increased by 35{\%} (P = 0.002). LE increased by 44{\%} (P = 0.03). CONCLUSIONS: Gd-BOPTA provides significantly higher CNR at 3 T compared with 1.5 T and also demonstrates significantly higher CNR when compared with a standard Gd-chelate at 3 T. As a result of transient protein binding, Gd-BOPTA may be superior to standard gadolinium chelates in neurologic imaging at 3 T.",
keywords = "Brain neoplasms, Contrast enhancement, Gadobenate dimeglumine, Gadolinium chelates, Magnetic resonance",
author = "Runge, {Val M.} and Jonmenjoy Biswas and Wintersperger, {Bernd J.} and Baumann, {Shannon S.} and Jackson, {Carney B.} and Herborn, {Christoph U.} and Patel, {Tushar C}",
year = "2006",
month = "3",
doi = "10.1097/01.rli.0000191332.24773.e7",
language = "English (US)",
volume = "41",
pages = "244--248",
journal = "Investigative Radiology",
issn = "0020-9996",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging

T2 - Comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model

AU - Runge, Val M.

AU - Biswas, Jonmenjoy

AU - Wintersperger, Bernd J.

AU - Baumann, Shannon S.

AU - Jackson, Carney B.

AU - Herborn, Christoph U.

AU - Patel, Tushar C

PY - 2006/3

Y1 - 2006/3

N2 - OBJECTIVES: The objectives of this study were to analyze the differences in contrast enhancement using gadobenate dimeglumine (Gd-BOPTA or MultiHance) at 3 T versus 1.5 T and to compare Gd-BOPTA with a standard gadolinium chelate, gadopentetate dimeglumine (Gd-DTPA or Magnevist), at 3 T in a rat glioma model. MATERIALS AND METHODS: Twelve rats with surgically implanted gliomas were randomized to either comparing Gd-BOPTA at 1.5 T versus 3 T (n = 7) or comparing Gd-BOPTA and Gd-DTPA at 3 T (n = 5). Matched T1-weighted spin-echo techniques were used for both comparisons and the order of examinations was randomized. Signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and lesion enhancement (LE) were evaluated using a region-of-interest analysis. A veterinary histopathologist evaluated all brain specimens. RESULTS: In the evaluation of Gd-BOPTA at 3 T and 1.5 T, there were significant increases in SNR, LE, and CNR at 3 T. Average increases in brain and tumor SNR were 93% (P < 0.0001) and 92% (P < 0.0001), respectively. CNR increased by 121% (P < 0.0001). Comparison of Gd-BOPTA and Gd-DTPA at 3 T demonstrated significantly higher CNR and LE with Gd-BOPTA. CNR increased by 35% (P = 0.002). LE increased by 44% (P = 0.03). CONCLUSIONS: Gd-BOPTA provides significantly higher CNR at 3 T compared with 1.5 T and also demonstrates significantly higher CNR when compared with a standard Gd-chelate at 3 T. As a result of transient protein binding, Gd-BOPTA may be superior to standard gadolinium chelates in neurologic imaging at 3 T.

AB - OBJECTIVES: The objectives of this study were to analyze the differences in contrast enhancement using gadobenate dimeglumine (Gd-BOPTA or MultiHance) at 3 T versus 1.5 T and to compare Gd-BOPTA with a standard gadolinium chelate, gadopentetate dimeglumine (Gd-DTPA or Magnevist), at 3 T in a rat glioma model. MATERIALS AND METHODS: Twelve rats with surgically implanted gliomas were randomized to either comparing Gd-BOPTA at 1.5 T versus 3 T (n = 7) or comparing Gd-BOPTA and Gd-DTPA at 3 T (n = 5). Matched T1-weighted spin-echo techniques were used for both comparisons and the order of examinations was randomized. Signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and lesion enhancement (LE) were evaluated using a region-of-interest analysis. A veterinary histopathologist evaluated all brain specimens. RESULTS: In the evaluation of Gd-BOPTA at 3 T and 1.5 T, there were significant increases in SNR, LE, and CNR at 3 T. Average increases in brain and tumor SNR were 93% (P < 0.0001) and 92% (P < 0.0001), respectively. CNR increased by 121% (P < 0.0001). Comparison of Gd-BOPTA and Gd-DTPA at 3 T demonstrated significantly higher CNR and LE with Gd-BOPTA. CNR increased by 35% (P = 0.002). LE increased by 44% (P = 0.03). CONCLUSIONS: Gd-BOPTA provides significantly higher CNR at 3 T compared with 1.5 T and also demonstrates significantly higher CNR when compared with a standard Gd-chelate at 3 T. As a result of transient protein binding, Gd-BOPTA may be superior to standard gadolinium chelates in neurologic imaging at 3 T.

KW - Brain neoplasms

KW - Contrast enhancement

KW - Gadobenate dimeglumine

KW - Gadolinium chelates

KW - Magnetic resonance

UR - http://www.scopus.com/inward/record.url?scp=33745893815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745893815&partnerID=8YFLogxK

U2 - 10.1097/01.rli.0000191332.24773.e7

DO - 10.1097/01.rli.0000191332.24773.e7

M3 - Article

C2 - 16481906

AN - SCOPUS:33745893815

VL - 41

SP - 244

EP - 248

JO - Investigative Radiology

JF - Investigative Radiology

SN - 0020-9996

IS - 3

ER -